Denali Therapeutics Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:DNLI) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -131.47 M-75.3 M-107.3 M-98.54 M-131.2 M -412.34 M Cash from investing activities 18.75 M157.94 M57.83 M20.77 M94.46 M 330.99 M Cash from financing activities -3.76 M1.62 M-778 K192.13 M219.04 M 412.02 M Free cash flow -131.47 M-75.3 M-107.3 M-98.54 M-131.2 M -412.34 M

News

DNLI Stock Surges 59.4% Year to Date: Is There More Room for Growth?

Regenxbio Shares Rise on Plans to Resubmit Navsunli BLA for MPS II

Denali to Sell Priority Review Voucher for $195M Cash Boost

Denali Therapeutics Inc. (DNLI) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Should You Buy, Sell or Hold BIIB Stock After it Rises Almost 12% YTD?

Denali Therapeutics: 'Strong Buy' On AVLAYAH Approval And End Of 2026 FTD-GRN Data

Leqembi Isn’t Enough To Save Biogen Momentum (NASDAQ:BIIB)

Stocks Settle Higher on Iran Peace Hopes and Tech Strength

Denali Stock Dips as Biogen-Partnered Parkinson's Disease Study Fails

Stocks Climb on US-Iran Peace Hopes and Strength in Chipmakers

Stocks Supported by US-Iran Peace Deal Optimism

DNLI Q1 Loss Narrower Than Expected, Avlayah Approval Boosts Prospects